Stemcells Inc (NASDAQ: STEM)


Last Updated: Sep-26-2016 10:39:47

STEM News & Stock Updates

Premium Research

Stemcells Inc (NASDAQ: STEM) Profile

Volume133,112
Open$1.4
Prior Close$1.4
Market Cap$0.02 B
PE Ratio
Beta0.1
Stemcells Inc. is engaged in research aimed at the development of therapies that would use stem and progenitor cells derived from fetal or adult sources to treat and possibly cure human diseases and injuries such as Parkinson's disease hepatitis diabetes and spinal cord injuries.
SymbolCompanyMarket cap
AMGNAmgen$131.43 B
GILDGilead Sciences Inc$107.58 B
CELGCelgene Corp$85.7 B
BIIBBiogen Inc Cmn$68.98 B
REGNRegeneron Pharmaceutical$42.96 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$29.98 B
ILMNIllumina Inc$26.29 B
VRTXVertex Pharmaceutic$22.83 B
INCYIncyte Corporation$16.78 B

STEM Earnings

1st Quarter Earnings$ ()
2nd Quarter Earnings$ ()
3rd Quarter Earnings$ ()
4th Quarter Earnings$ ()
PE Ratio0
EPS Growth0%
Recent Earnings$
Annual EPS$-1.92
Market Capitalization$0.02 B
Insider Shareholder %0.013%
Annual Revenue$0 B
Number of Shares Outstanding11,700 Shares
Institutional Shareholder %5.43%
Annual Net Income$-0.03B
TTM Net Profit Margin$-21366.67
One Year Return-74.65%
Three Year Return-355.5%
Five Year Return-94.27%
Five Year Revenue Growth-91.55%
Five Year Earnings Growth-81.91%
Five Year Dividend Growth0%
Last Quarter EPS$
Annual EPS$-1.92
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD%
PE Ratio
Recent Earnings$
Dividends per Share$
Stock Split Ratio1-12
beta0.1

STEM Key Stats

Last Price$1.44
Net Change$0.01 (0.7%)
Bid$1.42
Ask Price$1.44
Open Price$1.4
Previous Close Price$1.4
High Price$1.45
Low Price$1.39
Number of Trades1,831
Volume133,112
Fifty Two Week High$7.56 (2015-11-19)
Fifty Two Week Low$0.33 (2016-06-24)
Average Daily Volume1,263,472
Share Outstanding11,700 Shares
Total Dividend Payout$0/yr
Dividend Yield0%